The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

BACKGROUND AND OBJECTIVES: The calcimimetic cinacalcet reduced the risk of death or cardiovascular (CV) events in older, but not younger, patients with moderate to severe secondary hyperparathyroidism (HPT) who were receiving hemodialysis. To determine whether the lower risk in younger patients migh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin J Am Soc Nephrol
Autors principals: Parfrey, Patrick S., Drüeke, Tilman B., Block, Geoffrey A., Correa-Rotter, Ricardo, Floege, Jürgen, Herzog, Charles A., London, Gerard M., Mahaffey, Kenneth W., Moe, Sharon M., Wheeler, David C., Kubo, Yumi, Dehmel, Bastian, Goodman, William G., Chertow, Glenn M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422239/
https://ncbi.nlm.nih.gov/pubmed/25710802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07730814
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars